Pharmalytics Group is an independent, minority-owned Canadian consultancy specializing in health technology assessment (HTA), health economics and outcomes research (HEOR), and pharmaceutical market access. We partner with pharmaceutical and biotech companies to deliver high-quality, compliant, and strategically aligned reimbursement submissions across public and private payers.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 422 Richards St, Vancouver,british Columbia V6b 2z4,canada
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- pharmalyticsgroup.com
- Keywords
- HEOR, Health Technology Assessment, Evidence Synthesis, Advanced Analytics, Real-World Evidence, Decision Analytics, Economic Evaluation.
- HQ
- Vancouver, British Columbia
Pharmalytics Group Questions
Pharmalytics Group's website is pharmalyticsgroup.com
Pharmalytics Group's LinkedIn profile is https://ca.linkedin.com/company/pharmalyticsgroup
Pharmalytics Group has
7 employees.
View email and phone details for 7
employees at Pharmalytics Group.
Pharmalytics Group's industry is
Research Services
Pharmalytics Group's top competitors are
Open Health Heor & Market Access,
Bridge Medical Consulting,
Precisionheor,
Pharmacoevidence,
Broadstreet Health Economics & Outcomes Research,
Connectheor,
Evidinno Outcomes Research Inc.,
Medlior Health Outcomes Research Ltd.,
Raincity Analytics,
Ppd Real-World Evidence Solutions.
Pharmalytics Group's categories are Research Services
Pharmalytics Group's founding year is 2019
